Yayın:
Repeat Microvascular Decompression for Recurrent Trigeminal Neuralgia

dc.contributor.authorEser,P.
dc.contributor.authorUnal, H.S.
dc.contributor.authorKhezri, M.K.
dc.contributor.authorTürkkan, A.
dc.contributor.authorBekar, A.
dc.contributor.buuauthorEser, Pınar
dc.contributor.buuauthorÜNAL, HANSİDE SETENAY
dc.contributor.buuauthorBEKAR, AHMET
dc.contributor.buuauthorKhezri, Marzieh Karimi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentNöroşurji Ana Bilim Dalı
dc.contributor.scopusid59331628500
dc.contributor.scopusid59331628500
dc.contributor.scopusid6603677218
dc.contributor.scopusid57216947212
dc.date.accessioned2025-05-12T22:32:34Z
dc.date.issued2024-01-01
dc.description.abstractAIM: To review our experience with patients presenting with recurrent trigeminal neuralgia (TN) and who have undergone repeat microvascular decompression surgery (rMVD). MATERIAL and METHODS: This retrospective observational study was conducted at the Department of Neurosurgery at a university hospital. Patients who initially experienced complete pain relief after the first MVD but later had a recurrence of TN symptoms which required an rMVD were included in the study. Pain control outcomes were evaluated based on the Barrow Neurological Institute (BNI) scale score. RESULTS: Of the 375 patients who underwent MVD for TN over a 20-year period, 19 patients (6 females and 13 males) with a mean age of 57.68 ± 9.78 years developed symptom recurrence which necessitated an rMVD (5.06%). The average duration of the symptoms before the rMVD was 16.1 ± 19.36 months. The mean BNI score of the patients before the rMVD was 4.5 ± 0.5. Recurrence was primarily attributed to compression by a new offending vessel (n=9, 47.4%) or a Teflon granuloma (n=8, 42.1%). Two patients (10.5%) did not have any identifiable compression. During a follow-up period of 106.3 ± 58.3 months, excellent pain relief (BNI-I) was achieved in 10 patients (52.6%). Eight patients (42.1%) experienced a good outcome (BNI-III), and one patient (5.3%) experienced a poor outcome (BNI-IV). CONCLUSION: Recurrence of TN symptoms can occur even after an initially successful MVD. Subsequent MVDs should be considered as the primary treatment option for recurrent TN, as it significantly controls pain with low morbidity.
dc.identifier.doi10.5137/1019-5149.JTN.45323-23.1
dc.identifier.endpage826
dc.identifier.issn1019-5149
dc.identifier.issue5
dc.identifier.scopus2-s2.0-85204180132
dc.identifier.startpage819
dc.identifier.urihttps://hdl.handle.net/11452/51354
dc.identifier.volume34
dc.indexed.scopusScopus
dc.language.isoen
dc.publisherTurkish Neurosurgical Society
dc.relation.journalTurkish Neurosurgery
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTrigeminal neuralgia
dc.subjectRecurrence
dc.subjectPartial sensory rhizotomy
dc.subjectOutcome
dc.subjectMicrovascular decompression
dc.subject.scopusTrigeminal Neuralgia; Microvascular Decompression; Human Study
dc.titleRepeat Microvascular Decompression for Recurrent Trigeminal Neuralgia
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nöroşurji Ana Bilim Dalı
local.indexed.atScopus
relation.isAuthorOfPublication4d0f04a1-16bc-4fb0-b146-5959dea6339e
relation.isAuthorOfPublicatione929e321-8731-462f-8655-65e237321fef
relation.isAuthorOfPublication.latestForDiscovery4d0f04a1-16bc-4fb0-b146-5959dea6339e

Dosyalar